Aqua Bio Technology ASA (OSL:ABTEC)
Norway · Delayed Price · Currency is NOK 5.02
-0.18 (-3.46%)
At close: Sep 11, 2026
Aqua Bio Technology ASA Income Statement
Financials in millions NOK. Fiscal year is January - December.
Millions NOK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Revenue | 0.32 | 1.34 | 10.5 | 18.41 | 7.02 | 1.56 |
Other Revenue | 5.35 | 6.19 | 0.38 | 0.33 | 0.14 | 0.42 |
| 5.67 | 7.53 | 10.87 | 18.74 | 7.16 | 1.98 | |
Revenue Growth | - | -30.73% | -41.96% | 161.63% | 262.49% | 143.11% |
Cost of Revenue | 1.11 | 1.11 | 6.98 | 8.34 | 4.69 | 0.95 |
Gross Profit | 4.55 | 6.42 | 3.9 | 10.4 | 2.47 | 1.02 |
Selling, General & Admin | 9.1 | 17.13 | 35.57 | 36 | 21.52 | 17.79 |
Operating Expenses | 9.3 | 18.09 | 39.62 | 39.68 | 23.18 | 18.88 |
Operating Income | -4.75 | -11.67 | -35.73 | -29.28 | -20.71 | -17.86 |
Interest Expense | -7.76 | -12.22 | -10.54 | -4.49 | -2.24 | -1.46 |
Interest & Investment Income | 0.03 | 0.01 | 0.17 | 0.06 | 0 | - |
Currency Exchange Gain (Loss) | -0.01 | -0.01 | -1.41 | -0.31 | -0.15 | 0.2 |
Other Non Operating Income (Expenses) | -5.66 | - | -0.04 | -0.31 | - | - |
EBT Excluding Unusual Items | -18.16 | -23.89 | -47.55 | -34.34 | -23.1 | -19.11 |
Impairment of Goodwill | - | - | -2.67 | - | - | - |
Gain (Loss) on Sale of Investments | -10.05 | -0.75 | -23.38 | - | - | - |
Gain (Loss) on Sale of Assets | - | - | -44.71 | - | - | - |
Asset Writedown | - | - | -8.19 | -0.8 | - | - |
Other Unusual Items | - | - | 5.55 | 14.3 | 4.34 | - |
Pretax Income | -28.2 | -24.64 | -120.94 | -20.85 | -18.75 | -19.11 |
Income Tax Expense | 0.07 | - | -0.2 | 0.18 | -0.02 | - |
Earnings From Continuing Operations | -28.28 | -24.64 | -120.74 | -21.02 | -18.74 | -19.11 |
Earnings From Discontinued Operations | -2.41 | 122.34 | -242.64 | - | - | - |
Net Income | -30.69 | 97.71 | -363.38 | -21.02 | -18.74 | -19.11 |
Net Income to Common | -30.69 | 97.71 | -363.38 | -21.02 | -18.74 | -19.11 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 7 | 3 | 1 | 1 | 0 | 0 |
Shares Outstanding (Diluted) | 7 | 3 | 1 | 1 | 0 | 0 |
Shares Change | 272.72% | 85.97% | 122.82% | 47.34% | 7.88% | 18.67% |
EPS (Basic) | -4.47 | 38.60 | -267.00 | -34.42 | -45.39 | -49.73 |
EPS (Diluted) | -4.47 | 38.60 | -267.00 | -34.50 | -46.24 | -49.73 |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -6.34 | -8.15 | -57.27 | -19.34 | -15.45 | -20.97 |
Free Cash Flow Per Share | -0.92 | -3.22 | -42.08 | -31.67 | -37.27 | -54.56 |
Gross Margin | 80.35% | 85.22% | 35.83% | 55.51% | 34.52% | 51.82% |
Operating Margin | -83.84% | -154.89% | -328.56% | -156.29% | -289.21% | -903.89% |
Profit Margin | -541.63% | 1297.15% | -3341.77% | -112.21% | -261.62% | -967.45% |
Free Cash Flow Margin | -111.92% | -108.23% | -526.69% | -103.24% | -215.73% | -1061.42% |
EBITDA | -8.62 | -11.66 | -34.46 | -27.27 | -19.47 | -16.9 |
EBITDA Margin | -152.19% | -154.75% | - | -145.57% | -271.94% | - |
D&A For EBITDA | -3.87 | 0.01 | 1.27 | 2.01 | 1.24 | 0.96 |
EBIT | -4.75 | -11.67 | -35.73 | -29.28 | -20.71 | -17.86 |
EBIT Margin | -83.84% | -154.89% | - | -156.29% | -289.21% | - |
Revenue as Reported | 5.67 | 7.53 | 10.87 | 18.74 | 7.16 | 1.98 |